Hong Kong biotech innovation sector rebounds at market open, Xiaoyan Biotech rises over 5%

Hong Kong stocks’ innovative drug sector rebounds at the opening. Zhaoyan New Drug rises over 5%, WuXi Biologics up over 4%, Kanglong Chemical, Innovent Biologics, and Junshi Biosciences all advance.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin